Combining the long tradition of vaccine development of Ceva Phylaxia in Hungary and the cutting edge technology of Biomune in USA the company is committed to develop innovative vaccines that can meet the current needs to ensure that health of the animals and people is protected.
Developing antibiotics of the highest quality is a longstanding tradition at Ceva. The company has mastered the main anti-infective molecules currently on the world veterinary market.
Ceva provides practitioners with sound expertise in the sustainable use of veterinary anti-infectives. The majority of products developed are available in injectable form with different formulations to provide a fast or delayed (long) action.
Some of those injectable anti-infectives (Vetrimoxin® LA, Tenaline® LA, Spirovet®…) are presented in the innovative CLAS® (Ceva Layered Anti Shatter) vials. The use if this new technology ensures that the antibiotics can be bottled in lightweight, shock resistant, stable and easy to use vials.